← Back to Search

Hemodialysis Access Techniques for Chronic Kidney Disease in the Elderly (ELDERLY Trial)

N/A
Recruiting
Led By Eric K Peden, MD
Research Sponsored by E. Peden, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Expected to undergo hemodialysis within 6 months of presentation
Aged ≥70 years of all ethnicities
Must not have
Intraoperative decision was made in favor of fistula instead of graft
Unable or refuse to abide with follow-up
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare autologous arteriovenous fistulas (AVF) to hemodialysis access grafts in the elderly, enrolling 270 patients over 5 years.

Who is the study for?
This trial is for people aged 70 or older with advanced kidney disease who need hemodialysis and can have surgery to create a dialysis access. They must be currently on hemodialysis due to previous access failure, and not have bleeding disorders, active infections, certain vein issues unless recently imaged, or an inability to follow the study plan.
What is being tested?
The study compares two surgical methods for creating dialysis access in elderly patients: making a fistula from their own blood vessels or implanting a synthetic graft. It's randomized-controlled, meaning participants are randomly assigned to one of these two groups without knowing which one.
What are the potential side effects?
Possible side effects include complications at the surgery site like infection or clotting, problems with blood flow through the created access point leading to additional interventions, and general risks associated with anesthesia and surgical procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am expected to start hemodialysis within the next 6 months.
Select...
I am 70 years old or older.
Select...
My blood vessels are suitable for creating a connection for dialysis.
Select...
I am on hemodialysis due to previous access failure.
Select...
I have severe kidney disease and need dialysis.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My surgery involved creating a fistula instead of using a graft.
Select...
I cannot or will not follow the study's follow-up requirements.
Select...
I have a condition that affects how my blood clots.
Select...
I do not have any active infections.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Analyze hemodialysis (HD) access creation, arteriovenous (AV) fistula vs Graft, in elderly patients.
Functional cumulative patency rate at 12 months
Secondary study objectives
To compare and analyze the estimated costs with both types of hemodialysis interventions and their postoperative outcomes.
Using Disease Outcomes Quality Initiative quality of life tool to evaluate and compare the overall improvement in outcome with respect to morbidity in the 2 years post fistula/graft procedure
Using Disease Outcomes Quality Initiative quality of life tool to evaluate and compare the overall improvement in outcome with respect to mortality in the 2 years post fistula/graft procedure
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Surgical graft implantActive Control2 Interventions
Patients randomized to surgical graft, will have a commercially available graft surgically implanted to be used for hemodialysis access.
Group II: Surgical fistula creation from patient's anatomyActive Control1 Intervention
Patients randomized to surgical arteriovenous fistula will have a fistula surgically created from their anatomy to be used for hemodialysis access.

Find a Location

Who is running the clinical trial?

E. Peden, MDLead Sponsor
1 Previous Clinical Trials
20 Total Patients Enrolled
The Methodist Hospital Research InstituteOTHER
287 Previous Clinical Trials
81,510 Total Patients Enrolled
Eric K Peden, MDPrincipal InvestigatorThe Methodist Hospital Research Institute
Eric Peden, MDPrincipal InvestigatorThe Methodist Hospital Research Institute
2 Previous Clinical Trials
300 Total Patients Enrolled

Media Library

Surgical fistula creation from patient's anatomy Clinical Trial Eligibility Overview. Trial Name: NCT03065972 — N/A
Kidney Disease Research Study Groups: Surgical graft implant, Surgical fistula creation from patient's anatomy
Kidney Disease Clinical Trial 2023: Surgical fistula creation from patient's anatomy Highlights & Side Effects. Trial Name: NCT03065972 — N/A
Surgical fistula creation from patient's anatomy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03065972 — N/A
~2 spots leftby Feb 2025